127 related articles for article (PubMed ID: 3859250)
1. [Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Higuchi A; Miyazaki T; Sakurada K; Morioka M; Musashi M; Imamura M; Maekawa I; Saitoh H; Ohtani N; Kasai M
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1253-9. PubMed ID: 3859250
[TBL] [Abstract][Full Text] [Related]
2. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Tanaka I; Kobayashi T; Shirakawa S; Ikeda Y; Kobayashi M; Yamagata K; Ohta K; Ohno R; Yamada H; Yamada K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248
[TBL] [Abstract][Full Text] [Related]
3. [Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Masaoka T; Kimura K; Miyazaki T; Sakurada K; Saitoh H; Morioka M; Fujimoto N; Musashi M; Wakui A; Yokoyama M; Kanamaru R; Oguro M; Takagi T; Konda C; Saitoh T; Nakao I; Harashima S; Ohhashi Y; Sakai Y; Sasaki T; Ohno R; Katoh Y; Yamada K; Hirota Y; Takada T; Hoshino A; Ohara K; Kamiya O; Kojima T; Nagata K; Nakamura T; Sasada M; Yonezawa T; Tsubakio T; Kanayama Y; Kitani T; Taniguchi N; Yasunaga K; Okamoto Y; Fujitake H; Ohkubo A; Horiuchi A; Tsubaki K; Takubo T; Shibata H; Kawagoe H; Hirata M; Matsubuchi T; Nagai K; Fujita S
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1518-23. PubMed ID: 6347081
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of a new nitrosourea derivative, MCNU, in tablet form. Takai Blood Cancer Study Group].
Kobayashi T; Tanaka I; Shirakawa S; Fujiwara Y; Hirota Y; Kobayashi M; Ohno R; Yamada H; Mitomo Y; Yamamoto M
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1079-85. PubMed ID: 3566304
[TBL] [Abstract][Full Text] [Related]
5. [Phase II study on oral administration of MCNU (ranomustine) tablet. Hanshin Cooperative Study Group on Hematological Disorders].
Kanamaru A; Nagai K; Masaoka T; Shibata H; Kitani T; Taniguchi N; Horiuchi A; Tsubaki K; Kawagoe H; Hirata M
Gan To Kagaku Ryoho; 1986 May; 13(5):1915-20. PubMed ID: 3458432
[TBL] [Abstract][Full Text] [Related]
6. [Randomized controlled study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in comparison with busulfan for chronic myelogenous leukemia].
Masaoka T; Kimura K; Miyazaki T; Hirota Y; Nakamura T; Yasunaga K; Ohkubo H; Okamoto Y; Fujitake H; Kitani T
Gan To Kagaku Ryoho; 1985 May; 12(5):1111-8. PubMed ID: 3888116
[TBL] [Abstract][Full Text] [Related]
7. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
[TBL] [Abstract][Full Text] [Related]
8. [Prolonged remission in a patient with chronic myelocytic leukemia (CML) by methyl 6-[3-(2-chloroethyl)-3-deoxy-alpha-D-glucopyranoside (MCNU)].
Murase T; Nagura E; Ohno R
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2590-3. PubMed ID: 6594976
[TBL] [Abstract][Full Text] [Related]
9. [Discriminant analysis of bone marrow suppression of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Saito A; Oride M; Munaka M; Uozumi T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):511-5. PubMed ID: 3813579
[TBL] [Abstract][Full Text] [Related]
10. [Phase I study on oral administration of methyl-6-[[[(2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Kanamaru A; Nagai K; Fujita S; Masaoka T; Takubo T; Kitani T; Taniguchi N; Horiuchi A; Tsubaki K; Kawagoe H; Hirata M; Yonezawa T; Tsubakio T; Yasunaga K; Okamoto Y; Fujitake H; Ohkubo A
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1831-7. PubMed ID: 6882006
[TBL] [Abstract][Full Text] [Related]
11. A new nitrosourea derivative for the treatment of chronic myelogenous leukemia.
Hiraoka A; Masaoka T; Shibata H; Miyazaki T; Nakamura T; Yasunaga K; Kitani T; Yonezawa T; Kawagoe H; Horiuchi A
Leuk Res; 1988; 12(6):487-90. PubMed ID: 3043111
[TBL] [Abstract][Full Text] [Related]
12. [Clinical trial of bestrabucil (KM 2210) on hematopoietic malignancies].
Nishikawa M; Uemura Y; Matsuoka N; Ohno T; Katayama N; Tomeoku M; Kobayashi T; Kita K; Tanaka H; Minami N
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2155-9. PubMed ID: 3521494
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic effect of ranimustine (MCNU) on essential thrombocythemia and polycythemia vera].
Nagai M; Tasaka T; Kamano H; Ohnishi H; Taoka T; Ikeda K; Kubota Y; Tanaka T; Irino S
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3267-70. PubMed ID: 3196045
[TBL] [Abstract][Full Text] [Related]
14. [Ranimustine].
Masaoka T
Gan To Kagaku Ryoho; 1990 Feb; 17(2):301-7. PubMed ID: 2405779
[TBL] [Abstract][Full Text] [Related]
15. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
Taguchi T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
[TBL] [Abstract][Full Text] [Related]
16. [A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group].
Kimura K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):368-75. PubMed ID: 3947112
[TBL] [Abstract][Full Text] [Related]
17. Beneficial treatment with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in a patient with primary myelofibrosis.
Asano Y; Shimokawa M; Okabe H; Sanefuji H; Kato K
Acta Haematol; 1991; 85(2):103-4. PubMed ID: 2024552
[TBL] [Abstract][Full Text] [Related]
18. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
[TBL] [Abstract][Full Text] [Related]
19. [Action mechanism of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in leukemic cells].
Nakamura T; Hashimoto E; Sasada M; Tsutani H; Kagawa D; Ueda T; Uchida M; Domae N; Ando S; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1985 May; 48(3):734-41. PubMed ID: 3862320
[No Abstract] [Full Text] [Related]
20. [Therapeutic effect of ranimustine(MCNU) on myeloproliferative disorder and chronic myelomonocytic leukemia].
Maeda S; Okabe M; Kurosawa M; Kunieda Y; Imamura M; Morioka M; Sakurada K; Miyazaki T; Sukegawa M
Gan To Kagaku Ryoho; 1991 Feb; 18(2):251-8. PubMed ID: 1992919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
